HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 279, Issue 46, 47808-47814, November 12, 2004

This Article Full Text Full Text (PDF) Supplemental Data All Versions of this Article: 279/46/47808    most recent M406395200v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Razidlo, G. L. Articles by Lewis, R. E. Search for Related Content PubMed PubMed Citation Articles by Razidlo, G. L. Articles by Lewis, R. E. Social Bookmarking                      What's this?

Phosphorylation Regulates KSR1 Stability, ERK Activation, and Cell Proliferation^*

Gina L. Razidlo¶, Robert L. Kortum, Jamie L. Haferbier, and Robert E. Lewis||

From the Eppley Institute for Research in Cancer and Allied Diseases and the Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska 68198-7696

Kinase suppressor of Ras (KSR) is a molecular scaffold that interacts with the components of the Raf/MEK/ERK kinase cascade and positively regulates ERK signaling. Phosphorylation of KSR1, particularly at Ser³⁹², is a critical regulator of KSR1 subcellular localization and ERK activation. We examined the role of phosphorylation of both Ser³⁹² and Thr²⁷⁴ in regulating ERK activation and cell proliferation. We hypothesized that KSR1 phosphorylation is involved in generating signaling specificity through the Raf/MEK/ERK kinase cascade in response to stimulation by different growth factors. In fibroblasts, platelet-derived growth factor stimulation induces sustained ERK activation and promotes S-phase entry. Treatment with epidermal growth factor induces transient ERK activation but fails to drive cells into S phase. Mutation of Ser³⁹² and Thr²⁷⁴ (KSR1.TVSA) promotes sustained ERK activation and cell cycle progression with either platelet-derived growth factor or epidermal growth factor treatment. KSR1^–/– mouse embryo fibroblasts expressing KSR1.TVSA proliferate two times faster and grow to a higher density than cells expressing the same level of wild-type KSR1. In addition, KSR1.TVSA is more stable than wild-type KSR1. These data demonstrate that phosphorylation and stability of the molecular scaffold KSR1 are critical regulators of growth factor-specific responses that promote cell proliferation.

Received for publication, June 8, 2004 , and in revised form, August 24, 2004.

^* This research was supported by National Institutes of Health Grants CA90400 and CA36727. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The on-line version of this article (available at http://www.jbc.org) contains a supplementary figure showing fluorescent photomicrographs of anti-BrdUrd- and 4',6-diamidino-2-phenylindole-stained cells.

^¶ Supported by a predoctoral fellowship from the National Science Foundation.

^|| To whom correspondence should be addressed: Eppley Institute, University of Nebraska Medical Center, 987696 Nebraska Medical Center, Omaha, NE 68198-7696. Tel.: 402-559-8290; Fax: 402-559-3739; E-mail: rlewis{at}unmc.edu.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				E. M. Horvath, L. Tackett, A. M. McCarthy, P. Raman, J. T. Brozinick, and J. S. Elmendorf Antidiabetogenic Effects of Chromium Mitigate Hyperinsulinemia-Induced Cellular Insulin Resistance via Correction of Plasma Membrane Cholesterol Imbalance Mol. Endocrinol., April 1, 2008; 22(4): 937 - 950. [Abstract] [Full Text] [PDF]

				J. Szwaya, C. Bruseo, E. Nakuci, D. McSweeney, X. Xiang, D. Senator, D. France, and C.-R. Chen A Novel Platform for Accelerated Pharmacodynamic Profiling for Lead Optimization of Anticancer Drug Candidates J Biomol Screen, March 1, 2007; 12(2): 159 - 166. [Abstract] [PDF]

				A. M. McCarthy, K. O. Spisak, J. T. Brozinick, and J. S. Elmendorf Loss of cortical actin filaments in insulin-resistant skeletal muscle cells impairs GLUT4 vesicle trafficking and glucose transport Am J Physiol Cell Physiol, November 1, 2006; 291(5): C860 - C868. [Abstract] [Full Text] [PDF]

				R. L. Kortum, H. J. Johnson, D. L. Costanzo, D. J. Volle, G. L. Razidlo, A. M. Fusello, A. S. Shaw, and R. E. Lewis The Molecular Scaffold Kinase Suppressor of Ras 1 Is a Modifier of RasV12-Induced and Replicative Senescence. Mol. Cell. Biol., March 1, 2006; 26(6): 2202 - 2214. [Abstract] [Full Text] [PDF]

				L. K. Rushworth, A. D. Hindley, E. O'Neill, and W. Kolch Regulation and role of raf-1/b-raf heterodimerization. Mol. Cell. Biol., March 1, 2006; 26(6): 2262 - 2272. [Abstract] [Full Text] [PDF]

				S. E. Robertson, S. R. G. Setty, A. Sitaram, M. S. Marks, R. E. Lewis, and M. M. Chou Extracellular Signal-regulated Kinase Regulates Clathrin-independent Endosomal Trafficking Mol. Biol. Cell, February 1, 2006; 17(2): 645 - 657. [Abstract] [Full Text] [PDF]

				R. L. Kortum, D. L. Costanzo, J. Haferbier, S. J. Schreiner, G. L. Razidlo, M.-H. Wu, D. J. Volle, T. Mori, H. Sakaue, N. V. Chaika, et al. The Molecular Scaffold Kinase Suppressor of Ras 1 (KSR1) Regulates Adipogenesis Mol. Cell. Biol., September 1, 2005; 25(17): 7592 - 7604. [Abstract] [Full Text] [PDF]

				A. B. Strawbridge and J. S. Elmendorf Phosphatidylinositol 4,5-Bisphosphate Reverses Endothelin-1-Induced Insulin Resistance via an Actin-Dependent Mechanism Diabetes, June 1, 2005; 54(6): 1698 - 1705. [Abstract] [Full Text] [PDF]

				A. Laine and Z. Ronai Ubiquitin Chains in the Ladder of MAPK Signaling Sci. Signal., April 26, 2005; 2005(281): re5 - re5. [Abstract] [Full Text] [PDF]